Main Article Content
Introduction: Despite the rise of video consultation, most consultations in patients with digestive diseases tend to be face-to-face.
Objective and Methods: In 2016, gastroenterology video consultation was implemented in the hospital. A prospective and descriptive study of a series of patients attended consecutively by video consultation by a gastroenterology specialist for 50 months. We have analyzed which syndromes and digestive diseases are susceptible to being performed by video consultation.
Results: Two hundred fifty patients were selected (100 during the first three months of the COVID-19 pandemic), 50.4% men and 49.6% women, with a mean age of 48 (SD 18-9) years. The main reason for the consultation of the 142 patients (56.8%) with definitive diagnoses was: dyspepsia, hepatobiliary disease, diarrhea, gastroesophageal reflux, and irritable bowel syndrome. The final diagnosis was dyspepsia (21%), hepatobiliary disease (16%), diarrhea (9%), irritable bowel syndrome (8.4%), intolerances (including gluten intolerance and sensitivity) (8.4%), gastroesophageal reflux disease (7,7%), and inflammatory bowel disease (6.3%). The concordance between the diagnostic impression and the definitive diagnosis was 60%.
Conclusions: Video consultation in gastroenterology is an effective alternative to the face-to-face visit, used equally in patients of both sexes, where dyspepsia is the main reason for consultation and diagnosis. During the first 3 months of the COVID-19 pandemic, the number of video consultations increased 10 times. The main pathologies diagnosed were dyspepsia and hepatobiliary diseases.
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
2. Tuckson RV, Edmunds M, Hodgkins ML. Telehealth. N Engl J Med 2017; 377,1585-1592.
3. Zambrana-García JL, Montoro MI, Chicano M, et al. Eficacia de un sistema de consultas de alta resolución en gastroenterología en un centro hospitalario andaluz. Rev Esp Enferm Dig 2016; 108: 3-7.
4. Kane CK, Gillis K. Use of Telemedicine by physicians. Healt Aff 2018; 37: 1923-30.
5. Cross RK, Kane S. Integration of telemedicine into clinical gastroentrology and hepatology practice. Clin Gastroenterol Hepatol 2017; 15: 175-81.
6. Torrejón A, Masachs M, Borruel N et al. Aplicación de un modelo de asistencia continuada en la enfermedad inflamatoria intestinal: la unidad de atención Crohn-Colitis. Gastroentrol y Hepatol 2009; 32: 77-82.
7. Krier M, Kaltenbach T, McQuaid K, et al. Potential use of Telemedicine to provide outpatient care for IBD. Scand J Gastroenterol 2011; 106: 2063-7.
8. Huang VW, Reich KM, Fedorak RN. Distance mnagement of Inflammatory Bowel Disease: systematic review and meta-analysis. World J Gastroenterol 2014; 20: 829-42.
9. De Jong MJ, Van der Meulen-De Jong AE, Romberg-Camps MJ, et al. Telemedicine for management of inflammatory bowel disease (myIBDoach): a pragmatic, multicentre, randomized controlled trial. Lancet 2017; 390: 959-68.
10. Cross RK, Langenberg P, Regueiro M et al. A randomized controlled trial of telemedicine for patients with inflammatory bowel disease (TELE-IBD). Am J Gastroenterol 2019; 114: 472-82.
11. Del.Hoyo J, Nos P, Bastida G et al. Telemonitorización de la enfermedad de Crohn y la colitis ulcerosa (TECCU): análisis de coste-efectividad. J Med Internet Res 2019; 21: e15505.
12. Stotts MJ, Crischkan JA, Khungar V. Improving cirrosis care: the potential for telemedicine amd mobile health technologies. World J Gastroenterol 2019; 25: 3849-56.
13. Mauro E, Marciano S, Torres MC et al. Telemedicine improves access to hepatology consultation with high patient satisfaction. J Clin Experimental Hepatol 2020. In Press. https://doi.org/10.1016/j.jceh.2020.04.017
14. Editorial. The potential of Telemedicine in digestive diseases. Lancet Gastroentero Hepatol 2019; 4: 185.
15. Arora S. Project ECHO. Democratising knowledge for the elimination of viral hepatitis. Lancet Gastroenterol Hepatol 2019; 4: 91-3.
16. Helsel BC, Williams JE, Lawson K et al. Systematic review of Telemedicine in digestive diseases. Dig Dis Sci 2018; 63: 1392-1408.
17. Lee T, Kim L. Telemedicine in gastroenterology: A value added service of patients. Clin Gastroenterol Hepatol 2020; 18: 530-3.
18. Song X, liu X, Wang C. The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province. Critical Care 2020; 24: 178-81.
19. Huntzinger M, Bielefeldt K. Expanding the scope of Telemedicine in Gastroenterology. Fed Pract 2018; 35: 26-31.
20. Morcillo C, Tizon D, Marzal D, Tomás JF. Digital health solutions implemented by Sanitas hospitals to maintain continuity of care during COVID-19 pandemic. Medical Research Archives, [S.l.], v. 8, n. 8, aug. 2020. ISSN 2375-1924. https://doi.org/10.18103/mra.v8i8.2228
21. Alvarez PE, Castiblanco F, Correa AF y cols. Covid-19, médicos, gastroenterología y emociones. Rev Colombiana de Gastroenterología 2020; 35 (Supl 1): 64-68.
22. Serper M, Cubell AW, Deleener ME et al. Telemedicine in liver disease beyond: Can the COVID-19 crisis lead to action? Hepatology 2020; 72: 723-728 doi: 10.1002/hep.31276.